James Douglas Thornton (Douglas Thornton, Douglas J Thornton, J Douglas Thornton)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Hyaluronic Acid

Affordable Care Act

Drug Administration

Cross Sectional

Top Venues

Journal of occupational and environmental medicine

Health affairs scholar

American journal of clinical oncology

Aging & mental health

This page only lists publications with an associated author ORCID identifier.

Publications

Olajumoke Adenike Olateju, Osaro Mgbere, James Douglas Thornton, Zhen Zeng, Ekere James Essien
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint Inhibitors. American journal of clinical oncology (2024)
Olajumoke Adenike Olateju, Chan Shen, James Douglas Thornton
The Affordable Care Act and income-based disparities in health care coverage and spending among nonelderly adults with cancer. Health affairs scholar 2 (5) (2024)
Olajumoke Adenike Olateju, Chan Shen, James Douglas Thornton
The Affordable Care Act and income-based disparities in health care coverage and spending among nonelderly adults with cancer. Health affairs scholar 2 (5) (2024)
James Douglas Thornton, Tyler Varisco, Prachet Bhatt M Econ, Olajumoke Adenike Olateju, Mina Shrestha, Chan Shen
Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. Journal of occupational and environmental medicine 66 (3) (2023)
James Douglas Thornton, Tyler J Varisco, Prachet Bhatt M Econ, Olajumoke Adenike Olateju, Mina Shrestha, Chan Shen
Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey from 2010-2019. Journal of occupational and environmental medicine (2023)
James Douglas Thornton, Tyler Varisco, Prachet Bhatt M Econ, Olajumoke Adenike Olateju, Mina Shrestha, Chan Shen
Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. Journal of occupational and environmental medicine 66 (3) (2023)
Olajumoke Adenike Olateju, Zhen Zeng, James Douglas Thornton, Osaro Mgbere, Ekere James Essien
Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors. BMC cancer 23 (1) (2023)
Vaishnavi Tata, Randa Al Saadi, Sang Kyu Cho, Tyler J Varisco, Matthew A Wanat, James Douglas Thornton
Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis. BMC health services research 23 (1) (2023)
James Douglas Thornton, Tyler Varisco, Prachet Bhatt M Econ, Olajumoke Adenike Olateju, Mina Shrestha, Chan Shen
Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. Journal of occupational and environmental medicine 66 (3) (2023)
James Douglas Thornton, Tyler Varisco, Prachet Bhatt M Econ, Olajumoke Adenike Olateju, Mina Shrestha, Chan Shen
Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. Journal of occupational and environmental medicine 66 (3) (2023)
Precious Anyanwu, Tyler J Varisco, Matthew A Wanat, Shweta Bapat, Kasey R Claborn, James Douglas Thornton
Comparing Two Databases to Identify Access to Buprenorphine Treatment for Opioid Use Disorder. Journal of pain & palliative care pharmacotherapy 36 (2) (2022)
Shweta Bapat, Micki Washburn, Vaishnavi Tata, Marc L Fleming, Susan M Abughosh, Ekere James Essien, James Douglas Thornton
Barriers and Facilitators to DATA Waivered Providers Prescribing Buprenorphine: A Qualitative Analysis Applying the Theory of Planned Behavior. Substance use & misuse 57 (12) (2022)
James Douglas Thornton, Tyler J Varisco, Callie G Downs
Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas. Pharmacoepidemiology and drug safety 30 (4) (2021)
Jagadeswara Rao Earla, George J Hutton, James Douglas Thornton, Hua Chen, Michael L Johnson, Rajender R Aparasu
Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis. Pharmacotherapy 41 (5) (2021)
Jagadeswara Rao Earla, George J Hutton, James Douglas Thornton, Hua Chen, Michael L Johnson, Rajender R Aparasu
Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis. Patient preference and adherence 14 (2020)
James Douglas Thornton, Precious Anyanwu, Vaishnavi Tata, Tamara Al Rawwad, Marc L Fleming
Differences between pharmacists' perception of counseling and practice in the era of prescription drug misuse. Pharmacy practice 18 (1) (2020)
Arijita Deb, Usha Sambamoorthi, James Douglas Thornton, Bernard Schreurs, Kim E Innes
Direct medical expenditures associated with Alzheimer's and related dementias (ADRD) in a nationally representative sample of older adults - an excess cost approach. Aging & mental health 22 (5) (2017)